693
Views
38
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Quality of Life Profiles and Changes in the Course of Maintenance Treatment Among 1,015 Patients With Severe Opioid Dependence

, , , , , & show all
Pages 705-715 | Published online: 03 Nov 2010

REFERENCES

  • Alonso, J., Ferrer, M., Gandek, B., Ware, J. E., Jr., Aaronson, N. K., Mosconi, P., (2004). Health-related quality of life associated with chronic conditions in eight countries: Results from the International Quality of Life Assessment (IQOLA) Project. Quality of Life Research, 13, 283–298.
  • Astals, M., Domingo-Salvany, A., Buenaventura, C. C., Tato, J., Vazquez, J. M., Martin-Santos, R., (2008). Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment. Substance Use & Misuse, 43, 612–632.
  • Batki, S. L., Canfield, K. M., Smyth, E., & Ploutz-Snyder, R. (2009). Health-related quality of life in methadone maintenance patients with untreated hepatitis C virus infection. Drug and Alcohol Dependence, 101, 176–182.
  • Bizzarri, J., Rucci, P., Vallotta, A., Girelli, M., Scandolari, A., Zerbetto, E., (2005). Dual diagnosis and quality of life in patients in treatment for opioid dependence. Substance Use & Misuse, 40, 1765–1776.
  • Brogly, S., Mercier, C., Bruneau, J., Palepu, A., & Franco, E. (2003). Towards more effective public health programming for injection drug users: Development and evaluation of the injection drug user quality of life scale. Substance Use & Misuse, 38, 965–992.
  • Bullinger, M. (2002). Assessing health related quality of life in medicine: An overview over concepts, methods and applications in international research. Restorative Neurology and Neuroscience, 20, 93–101.
  • Cohen, J. (1988). Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Earlbaum Associates.
  • Darke, S., Hall, W., Wodak, A., Heather, N., & Ward, J. (1992). Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: The Opiate Treatment Index. British Journal of Addiction, 87, 733–742.
  • Darke, S., Ward, J., Zador, D., & Swift, G. (1991). A scale for estimating the health status of opioid users. British Journal of Addiction, 86, 1317–1322.
  • Derogatis, L. R. (1983). SCL-90-R: Administration, scoring and procedures. Manual II. Towsen, MD: Clinical Psychometric Research.
  • Derogatis, L. R., Rickels, K., & Rock, A. F. (1976). The SCL-90 and the MMPI: A step in the validation of a new self-report scale. British Journal of Psychiatry, 128, 280–289.
  • Eklund, C., Melin, L., Hiltunen, A., & Borg, S. (1994). Detoxification from methadone maintenance treatment in Sweden: Long-term outcome and effects on quality of life and life situation. International Journal of Addiction, 29, 627–645.
  • Giacomuzzi, S. M., Riemer, Y., Kemmler, G., Ertl, M., Richter, R., Rossler, H., (2001). Subjective wellbeing and somatic markers in methadone substitution: Evaluation of 61 heroin addicts. Fortschritte Medizin, 119, 103–108.
  • Gsellhofer, B., & Fahrner, E. M. (1994). European Addiction Severity Index EuropASI. Manual für Training und Durchführung von Interviews mit dem EuropASI. In IFT Institut für Therapieforschung: München.
  • Haasen, C., Verthein, U., Degkwitz, P., Berger, J., Krausz, M., & Naber, D. (2007). Heroin-assisted treatment for opioid dependence: Randomised controlled trial. British Journal of Psychiatry, 191, 55–62.
  • Karow, A., Schafer, I., Hirdes, F., Osterwald, C., & Naber, D. (2008a). Subjective view of positive symptoms and quality of life in patients with schizophrenia. Psychiatrische Praxis, 35, 286–293.
  • Karow, A., Verthein, U., Krausz, M., & Schafer, I. (2008b). Association of personality disorders, family conflicts and treatment with quality of life in opiate addiction. European Addiction Research, 14, 38–46.
  • Kastelic, A., Dubajic, G., & Strbad, E. (2008). Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression. Addiction, 103, 1837–1846.
  • Katschnig, H. (2006). Quality of life in mental disorders: Challenges for research and clinical practice. World Psychiatry, 5, 139–145.
  • Katschnig, H., Angermeyer, M. C., Katschnig, H., Freeman, H., & Sartorius, N. (2005). Quality of life in depression. In Katschnig, H. and Angermeyer, M. C., Ed.: Katschnig, H., Freeman, H. and Sartorius, N. Quality of life in mental disorders (pp. 3–17). Chicester: Wiley.
  • Kennedy, S. H., Eisfeld, B. S., & Cooke, R. G. (2001). Quality of life: An important dimension in assessing the treatment of depression? Journal of Psychiatry and Neuroscience, 26(Suppl), 23–28.
  • Kleinig, J., & Einstein, S. (2006). Ethical challenges for intervening in drug use: Policy. Huntsville, TX: Research and Treatment Issues OICJ.
  • Kokkevi, A., & Hartgers, C. (1995). EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. European Addiction Research, 1(4), 208–210.
  • Laudet, A. B., Becker, J. B., & White, W. L. (2009). Don't wanna go through that madness no more: Quality of life satisfaction as predictor of sustained remission from illicit drug misuse. Substance Use & Misuse, 44, 227–252.
  • Maremmani, I., Pani, P. P., Pacini, M., Perugi, G. (2007). Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients. Journal of Substance Abuse Treatment, 33, 91–98.
  • McGahan, P. L., Parente, J. A., Parente, R., & McLellan, A. T. (1986). Addiction severity index: Composite scores manual. Pennsylvania: Veterano Administration Press.
  • McHorney, C. A., Ware, J. E., & Raczek, A. E. (1993). The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care, 31(3), 247–263.
  • Miller, P. G., & Miller, W. R. (2009). What should we be aiming for in the treatment of addiction? Addiction, 104, 685–686.
  • Millson, P. E., Challacombe, L., Villeneuve, P. J., Fischer, B., Strike, C. J., Myers, T., (2004). Self-perceived health among Canadian opiate users: A comparison to the general population and to other chronic disease populations. Canadian Journal of Public Health, 95, 99–103.
  • Perneger, T. V., Giner, F., del Rio, M., & Mino, A. (1998). Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. British Medical Journal, 317, 13–18.
  • Ponizovsky, A. M., & Grinshpoon, A. (2007). Quality of life among heroin users on buprenorphine versus methadone maintenance. American Journal of Drug and Alcohol Abuse, 33, 631–642.
  • Ponizovsky, A. M., Margolis, A., Heled, L., Rosca, P., Radomislensky, I., & Grinshpoon, A. (2010). Improved quality of life, clinical, and psychosocial outcomes among heroin-dependent patients on ambulatory buprenorphine maintenance. Substance Use & Misuse, 45(1–2), 288–313.
  • Prince, P. N., & Prince, C. R. (2001). Subjective quality of life in the evaluation of programs for people with serious and persistent mental illness. Clinical Psychology Review, 21, 1005–1036.
  • Pukrop, R., Moller, H. J., & Steinmeyer, E. M. (2000). Quality of life in psychiatry: A systematic contribution to construct validation and the development of the integrative assessment tool “modular system for quality of life.” European Archives of Psychiatry and Clinical Neuroscience, 250, 120–132.
  • Pukrop, R., Schlaak, V., Moller-Leimkuhler, A. M., Albus, M., Czernik, A., Klosterkotter, J., (2003). Reliability and validity of quality of life assessed by the short-form 36 and the modular system for quality of life in patients with schizophrenia and patients with depression. Psychiatry Research, 119, 63–79.
  • Richter, D., Eikelmann, B., & Berger, K. (2004). Use of the SF-36 in the evaluation of a drug detoxification program. Quality of Life Research, 13, 907–914.
  • Ruhrmann, S., Paruch, J., Bechdolf, A., Pukrop, R., Wagner, M., Berning, J., (2008). Reduced subjective quality of life in persons at risk for psychosis. Acta Psychiatrica Scandinavica, 117, 357–368.
  • Schäfer, A., Wittchen, H. U., Backmund, M., Soyka, M., Golz, J., Siegert, J., (2009). Psychopathological changes and quality of life in hepatitis C virus-infected, opioid-dependent patients during maintenance therapy. Addiction, 104, 630–640.
  • Scheurich, A., Muller, M. J., Wetzel, H., Anghelescu, I., Klawe, C., Ruppe, A., (2000). Reliability and validity of the German version of the European Addiction Severity Index (EuropASI). Journal of Studies on Alcohol, 61, 916–919.
  • Schwartz, R. P., Brooner, R. K., Montoya, I. D., Currens, M., & Hayes, M. (1999). A 12-year follow-up of a methadone medical maintenance program. American Journal of Addiction, 8, 293–299.
  • Torrens, M., Domingo-Salvany, A., Alonso, J., Castillo, C., & San, L. (1999). Methadone and quality of life. Lancet, 353, 1101.
  • Ventegodt, S., & Merrick, J. (2003). Psychoactive drugs and quality of life. Scientific World Journal, 3, 694–706.
  • Verthein, U., Degkwitz, P., Haasen, C., & Krausz, M. (2005). Significance of comorbidity for the long-term course of opiate dependence. European Addiction Research, 11, 15–21.
  • Ware, J. E., & Gandek, B. (1998). Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. Journal of Clinical Epidemiology, 51, 903–912.
  • Wasserman, D. A., Sorensen, J. L., Delucchi, K. L., Masson, C. L., & Hall, S. M. (2006). Psychometric evaluation of the Quality of Life Interview, Brief Version, in injection drug users. Psychology of Addictive Behaviors, 20(3), 316–321.
  • World Health Organization. (1993). The ICD-10 classification of mental and behavioural disorders: Diagnostic criteria for research. WHO.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.